Navigation Links
CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
Date:7/22/2008

- State-of-the-Art PET Study Confirms Tyrima Exhibits Excellent Drug-Like

Properties -

- Results Support Initiation of Phase II Clinical Trials -

RESEARCH TRIANGLE PARK, N.C., July 22 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today announced plans to advance its lead candidate Tyrima(TM) into Phase II trials for the treatment of depression and anxiety. This milestone is based on the positive results of the Tyrima Phase I program reported earlier this year and the recent completion of PET brain imaging studies showing that Tyrima penetrates the CNS and exhibits excellent pharmacokinetic and pharmacodynamic properties. Tyrima is a selective and reversible member of a novel class of drugs known as RIMAs, or reversible inhibitors of monoamine oxidase A (MAO-A).

"Tyrima has the potential to be the first triple-action antidepressant with a safety profile capable of treating a broad patient population, and we are very pleased with the promising properties Tyrima exhibited in these PET imaging studies," said Barry Brand, Chief Executive Officer of CeNeRx. "These encouraging results support our plans to initiate Phase II Tyrima trials in patients with major depression later this year."

"This innovative study used state-of-the-art PET imaging technology to demonstrate that Tyrima is penetrating and being eliminated from the brain in a consistent, predictable fashion," said Dr. Daniel Burch, Executive Vice President of R&D and Chief Medical Officer of CeNeRx. "Furthermore, the study has shown that plasma levels of Tyrima correlate extremely well with the action of Tyrima on MAO-A in the brain. This excellent pharmacokinetic/pharmacodynamic correlation has further increased our level of confidence in dose selection and the ability to demonstrate clinical efficacy as we move Tyrima into Phase
'/>"/>

SOURCE CeNeRx BioPharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
4. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
5. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
6. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
7. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
8. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
9. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
10. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
11. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 BRIC Biopsy Devices ... GlobalData,s new report, "BRIC Biopsy Devices Market Outlook ... Biopsy Devices market. The report provides value, in millions ... (in US dollars) within market segments - Biopsy Guns ... Fine Aspiration Needles (Disposable and Reusable Fine Aspiration Needles) ...
(Date:9/17/2014)... , Sept. 17, 2014  Levi & Korsinsky, ... connection with possible claims of breaches of fiduciary duty ... To get more information, click here: http://zlk.9nl.com/alexza-pharmaceuticals-alxa ... If you own common stock in Alexza ... contact Eduard Korsinsky, Esq. either via email ...
(Date:9/17/2014)... Sept. 17, 2014 Prostate Oncology Specialists ... campaign to educate men about new imaging technology ... the prostate. Annually, a million men undergo random ... rectum. Multi-parametric MRI (MP-MRI) of the prostate gland is ... Men need to be fully informed of their ...
Breaking Medicine Technology:BRIC Biopsy Devices Market Outlook to 2020 2BRIC Biopsy Devices Market Outlook to 2020 3Prostate Cancer Awareness Month - Stop Random Biopsies 2Prostate Cancer Awareness Month - Stop Random Biopsies 3
... Alcohol Abuse Among ADHD Patients Nearly Triple ... People, INDIANAPOLIS, May 23, 2007 /PRNewswire-FirstCall/ -- ... (atomoxetine HCl),improved symptoms of Attention- Deficit/Hyperactivity Disorder,(ADHD) ... suggesting,ADHD can be treated safely and effectively ...
... Otsuka Pharmaceutical Co, Ltd. Sponsored Study,Presented at ... SAN DIEGO, May 23, 2007 /PRNewswire/ -- ... years old) with schizophrenia, the Otsuka,Pharmaceutical Co., ... demonstrated significant improvement,compared to placebo on the ...
Cached Medicine Technology:Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9
(Date:9/18/2014)... (PRWEB) September 18, 2014 A positive outlook ... and improve your health. This year, at the Weekend for ... announce that adored LA radio talk show host Mother Love ... living with diabetes. , The always-funny Jo Anne Hart, ... is best known for her widely acclaimed talk show on ...
(Date:9/18/2014)... It is true that a business-oriented hosting solution ... brand or business online. Best Cheap Hosting USA, ... of professional web hosting suppliers and announced that ... the best VPS hosting suppliers in 2014. , ... businesses or enterprises can find the right hosting ...
(Date:9/18/2014)... September 18, 2014 Finding the perfect ... many dieters feeling that their weight loss struggle will ... trained in the science of fast weight loss, patients ... negative side effects. In fact, a recent in-house survey ... an average of 20 pounds during the first month ...
(Date:9/18/2014)... 2014 Texas Physical Therapy Specialists (TexPTS) ... Hispanic Physicians Association (HPA) Friends and Family Golf ... Texas. , The tournament, which will take place at ... for student scholarships through three golf challenges, “Top Scramble”, ... Equipment is provided at the event and there ...
(Date:9/18/2014)... SMI (Silicon Microstructures, Inc.) ... sensor Series designed especially for cost sensitive applications ... and differential offering allows for optimal signal resolution ... accuracy provide the user high performance while the ... reliability and long-term reliability needed for critical applications. ...
Breaking Medicine News(10 mins):Health News:DiabetesSisters Showcases Radio Talk Show Host Mother Love at Weekend for Women Conference in Los Angeles 2Health News:Best Cheap Hosting USA: GreenGeeks, Arvixe And iPage Are The Best Hosting Suppliers In 2014 2Health News:Diet Doc Discloses the Results of a Recent In-House Survey Revealing an Average Loss of 20 Pounds Per Month with Their No Carb Diet Plans 2Health News:Diet Doc Discloses the Results of a Recent In-House Survey Revealing an Average Loss of 20 Pounds Per Month with Their No Carb Diet Plans 3Health News:Texas Physical Therapy Specialists Sponsoring HPA Friends & Family Golf Tournament 2Health News:SMI Launches Digital MEMS Low Pressure Sensor 2
... (HealthDay News) -- Cardiac arrest victims are more likely to ... and after using a defibrillator to deliver an electric shock ... the cases of 815 American and Canadian patients who suffered ... (EMS) paramedics using either an automated external defibrillator or a ...
... WASHINGTON Synthetic fat substitutes used in low-calorie potato ... weight gain and obesity, according to a study published ... researchers at Purdue University, challenges the conventional wisdom that ... "Our research showed that fat substitutes can interfere with ...
... MONDAY, June 20 (HealthDay News) -- The U.S. Food and ... the safety and quality of imported drugs and food products. ... and increased data sharing, was created in response to rapidly ... chain. The strategy is outlined in a special report called ...
... the weather gets warmer, many parents will turn to pools ... and ease of use, portable pools - which include wading ... an increasingly popular alternative to expensive in-ground pools or water ... for children to cool off during hot summer days, a ...
... Cambridge University has for the first time found that ... The Medical Research Council (MRC) funded study, published ... Disorders , has important implications for service provision in ... Professor Simon Baron-Cohen, Director of the Autism Research ...
... ON (June 20, 20122) - Women with urinary incontinence ... develop postpartum depression as those without incontinence, according to ... in McMaster University,s School of Nursing. Postpartum depression ... in the family. According to the Canadian Mental Health ...
Cached Medicine News:Health News:Faster Transition From CPR to Defibrillator May Save Lives 2Health News:Fat substitutes linked to weight gain 2Health News:FDA to Step Up Inspections of Imported Products 2Health News:New study uncovers the dangers of portable pools 2Health News:Diagnosed autism is more common in an IT-rich region 2Health News:Diagnosed autism is more common in an IT-rich region 3Health News:Urinary incontinence doubles risk of postpartum depression 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: